(VIANEWS) – The NASDAQ ended the session with Seattle Genetics (SGEN) rising 4.8% to $142.15 on Monday while NASDAQ slid 1.2% to $11,662.79.


Today’s last reported volume for Seattle Genetics is 1677080, 60.13% above its average volume of 1047300.

Seattle Genetics’s last close was $135.63, 29.65% under its 52-week high of $192.79.

Seattle Genetics’s Sales

Seattle Genetics’s sales growth is a negative 32.3% for the ongoing quarter and 39.7% for the next. The company’s growth estimates for the present quarter is a negative 191.1% and positive 32.8% for the next.

Seattle Genetics’s Revenue

Year-on-year quarterly revenue growth declined by 28.5%, now sitting on 1.57B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Seattle Genetics’s stock is considered to be oversold (<=20).

Seattle Genetics’s Stock Yearly Top and Bottom Value

Seattle Genetics’s stock is valued at $142.15 at 18:17 EST, way below its 52-week high of $192.79 and way above its 52-week low of $105.43.

Seattle Genetics’s Moving Average

Seattle Genetics’s value is above its 50-day moving average of $138.43 and below its 200-day moving average of $151.25.

More news about Seattle Genetics (SGEN).


Please enter your comment!
Please enter your name here